Publication
Essential Corporate News: Week ending 24 May 2024
On 21 May 2024 the Financial Conduct Authority (FCA) published Primary Market Bulletin 49 (PMB 49) covering a range of topics covering a range of areas including those summarised below.
Author:
Publication | March 2017
Treaty/Act: CETA/Bill C-30 (An Act to implement the Comprehensive Economic and Trade Agreement between Canada and the European Union and its Member States and to provide for certain other measures)
Date: March 7, 2017 – Bill C-30 passes second reading in Senate and is referred to Senate’s Standing Committee on Foreign Affairs and International Trade
Major reforms to Canada’s Patent Act are coming as the Canadian Parliament moves one step closer to ratifying the Comprehensive Economic and Trade Agreement (CETA). On March 7, 2017, Bill C-30 (the Act intended to implement CETA into Canadian law) passed its second reading in the Senate, placing it in the final stages of the legislative process. Recent media reports indicate the European Union’s trade chief expects that Canada will ratify CETA within weeks.1
As we reported, CETA and Bill C-30 provide key reforms to the Patent Act affecting the pharmaceutical industry, including:
Are you CETA ready? Contact Norton Rose Fulbright with all your CETA questions.
Bill C-30, Third Reading (House of Commons)
Text of the final Comprehensive Economic and Trade Agreement
1. http://globalnews.ca/news/3324454/canada-eu-to-ratify-free-trade-pact/
Publication
On 21 May 2024 the Financial Conduct Authority (FCA) published Primary Market Bulletin 49 (PMB 49) covering a range of topics covering a range of areas including those summarised below.
Publication
As the world enters the age of artificial intelligence, the use of technology in the legal sector continues to create interpretative difficulties and misunderstandings, sometimes with serious consequences, over seemingly trivial matters.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023